Conditions: Chronic Kidney Disease
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 35
Healthy volunteers: no

Brief summary:
To assess the effects of 12 weeks of treatment with lanthanum carbonate compared with placebo on serum intact Fibroblast Growth Factor 23 (FGF23) levels.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Lanthanum carbonate intervention 2: Placebo
Intervention descriptions: intervention 1: 1000 mg in chewable tablets administered three times a day (for a total of 3000 mg/day) for 12 weeks intervention 2: Matching placebo chewable tablets administered 3 times a day for 12 weeks

Protocol document: